Germany

Comment

Third patient declared HIV-free following bone marrow transplant

GlobalData Healthcare

//$tag = get_term_by('slug', 'featured', 'post_tag');

News

German regulator approves NeuroSense’s CTA to enrol subjects in ALS trial

//$tag = get_term_by('slug', 'featured', 'post_tag');

News

Boehringer Ingelheim reports positive data from trial of spesolimab for GPP

News

Theriva doses first patient in pancreatic ductal adenocarcinoma trial

News

BioNTech begins Phase I study of vaccine candidate for Malaria

Comment

Merck expands haematology portfolio with acquisition of Imago for $1.35bn

News

Apogenix’s asunercept shown to offer benefits in Phase II Covid-19 trial

News

EpiEndo begins trial of chronic obstructive pulmonary disease treatment

News

Kinarus doses first subject in Phase II Covid-19 drug combination trial

Vishnu Priyan

News

ReAlta doses first subjects in Phase Ib severe asthma therapy trial

Vishnu Priyan

News

Boehringer’s IPF therapy slows lung function decline in Phase II trial

Vishnu Priyan

News

Unlearn.AI, Merck KGaA collaborate to expedite immunology trials

Vishnu Priyan

News

CureVac doses first subject in Phase I influenza vaccine trial

Vishnu Priyan

Comment

Encouraging pipeline for patients with Fragile X Syndrome

GlobalData Healthcare

News

Boehringer Ingelheim and Amgen collaborate on cancer trial

Aninda Chakraborty

News

Boehringer to start Phase III study of alteplase to treat Covid-19

Divya Tirumalaraju

News

CureVac’s CVnCoV vaccine shows 48% efficacy in Phase IIb/III trial

Divya Tirumalaraju

News

Vasopharm’s ronopterin fails in traumatic brain injury trial

Vishnu Priyan

Comment

Boehringer’s BI 425809 hints at cognitive improvement in schizophrenia patients

GlobalData Healthcare

News

Sandoz to study biosimilar aflibercept in Phase III AMD trial

Divya Tirumalaraju

News

Noxxon Pharma secures DSMB approval to continue brain cancer study

Aninda Chakraborty

News

Brainlab acquires image reading software provider Mint Medical

Vishnu Priyan

News

CureVac begins Phase III trial of Covid-19 vaccine candidate

Vishnu Priyan

News

Boehringer initiates trial of novel SARS-CoV-2 neutralising antibody

Vishnu Priyan

News

Parexel’s EPCU Berlin and CTC North partner on clinical trial research

Srivani Venna

News

Boehringer and Lilly’s Jardiance lowers total cardiovascular events risk

Vishnu Priyan

News

Boehringer’s nintedanib slows lung function decline in study

Vishnu Priyan

News

Boehringer initiates trial of targeted therapy to treat Covid-19 patients

Vishnu Priyan

News

Pfizer’s Ibrance fails in Phase III early breast cancer trial

Vishnu Priyan

News

CureVac begins Phase IIa trial of Covid-19 vaccine

Vishnu Priyan

News

Boehringer’s drug improves cognition in Phase II schizophrenia trial

Divya Tirumalaraju

Company News

Pfizer, BioNTech get German approval for second Covid-19 vaccine trial

Divya Tirumalaraju

News

Boehringer starts enrolment for paediatric trial of nintedanib

Divya Tirumalaraju

News

PCI Pharma creates new Clinical Center of Excellence in Germany

Himaja Ganta

News

CureVac to trial Covid-19 vaccine in Germany and Belgium

Divya Tirumalaraju

News

Atriva Therapeutics to conduct Phase II Covid-19 trial

Divya Tirumalaraju

News

Germany’s BfArM approves Covid-19 trial by Immunic

Divya Tirumalaraju

Features

Pfizer: How one of the world’s largest pharma firms is tackling Covid-19

Jamie Bell